These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11026542)

  • 41. Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptase.
    Corbett JW; Kresge KJ; Pan S; Cordova BC; Klabe RM; Rodgers JD; Erickson-Viitanen SK
    Bioorg Med Chem Lett; 2001 Feb; 11(3):309-12. PubMed ID: 11212098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of pyrryl aryl sulfones targeted at the HIV-1 reverse transcriptase.
    Artico M; Silvestri R; Stefancich G; Massa S; Pagnozzi E; Musu D; Scintu F; Pinna E; Tinti E; La Colla P
    Arch Pharm (Weinheim); 1995 Mar; 328(3):223-9. PubMed ID: 7539250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Zhan P; Liu X; Fang Z; Li Z; Pannecouque C; De Clercq E
    Eur J Med Chem; 2009 Nov; 44(11):4648-53. PubMed ID: 19628308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity.
    Campiani G; Nacci V; Fiorini I; De Filippis MP; Garofalo A; Greco G; Novellino E; Altamura S; Di Renzo L
    J Med Chem; 1996 Jul; 39(14):2672-80. PubMed ID: 8709096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-nucleoside reverse transcriptase inhibitors (Part 18): synthesis and anti-HIV activity of 4-allylamino or 4-azido substituted diaryltriazines.
    Xiong YZ; Hu HR; Chen FE; Balzarini J; Pannecouque C; de Clercq E
    Yao Xue Xue Bao; 2009 Feb; 44(2):145-9. PubMed ID: 19408683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1.
    Gudmundsson KS; Sebahar PR; Richardson LD; Miller JF; Turner EM; Catalano JG; Spaltenstein A; Lawrence W; Thomson M; Jenkinson S
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5048-52. PubMed ID: 19640718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1.
    Meadows DC; Sanchez T; Neamati N; North TW; Gervay-Hague J
    Bioorg Med Chem; 2007 Jan; 15(2):1127-37. PubMed ID: 17074494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.
    Bahare RS; Ganguly S; Choowongkomon K; Seetaha S
    Daru; 2015 Jan; 23(1):6. PubMed ID: 25617150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors.
    Monforte AM; Rao A; Logoteta P; Ferro S; De Luca L; Barreca ML; Iraci N; Maga G; De Clercq E; Pannecouque C; Chimirri A
    Bioorg Med Chem; 2008 Aug; 16(15):7429-35. PubMed ID: 18585918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2H-Pyrrolo[3,4-b] [1,5]benzothiazepine derivatives as potential inhibitors of HIV-1 reverse transcriptase.
    Di Santo R; Costi R
    Farmaco; 2005 May; 60(5):385-92. PubMed ID: 15910811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The structure-activity relationships of 2,4(1H,3H)-pyrimidinedione derivatives as potent HIV type 1 and type 2 inhibitors.
    Buckheit RW; Hartman TL; Watson KM; Kwon HS; Lee SH; Lee JW; Kang DW; Chung SG; Cho EH
    Antivir Chem Chemother; 2007; 18(5):259-75. PubMed ID: 18046959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Chen X; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Eur J Med Chem; 2012 May; 51():60-6. PubMed ID: 22405288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
    Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
    Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors.
    Gawali R; Trivedi J; Bhansali S; Bhosale R; Sarkar D; Mitra D
    Eur J Med Chem; 2018 Sep; 157():310-319. PubMed ID: 30099253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis and biological evaluation of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties.
    Sriram D; Bal TR; Yogeeswari P
    Bioorg Med Chem; 2004 Nov; 12(22):5865-73. PubMed ID: 15498662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and anti-HIV-1 activity of 1-substiuted 6-(3-cyanobenzoyl) and [(3-cyanophenyl)fluoromethyl]-5-ethyl-uracils.
    Loksha YM; Pedersen EB; Loddo R; La Colla P
    Arch Pharm (Weinheim); 2009 Sep; 342(9):501-6. PubMed ID: 19637180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, microwave-assisted synthesis and HIV-RT inhibitory activity of 2-(2,6-dihalophenyl)-3-(4,6-dimethyl-5-(un)substituted-pyrimidin-2-yl)thiazolidin-4-ones.
    Chen H; Bai J; Jiao L; Guo Z; Yin Q; Li X
    Bioorg Med Chem; 2009 Jun; 17(11):3980-6. PubMed ID: 19411176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.
    Barreca ML; Balzarini J; Chimirri A; De Clercq E; De Luca L; Höltje HD; Höltje M; Monforte AM; Monforte P; Pannecouque C; Rao A; Zappalà M
    J Med Chem; 2002 Nov; 45(24):5410-3. PubMed ID: 12431069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Famiglini V; La Regina G; Coluccia A; Pelliccia S; Brancale A; Maga G; Crespan E; Badia R; Clotet B; Esté JA; Cirilli R; Novellino E; Silvestri R
    Eur J Med Chem; 2014 Jun; 80():101-11. PubMed ID: 24769348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Non-nucleoside inhibitors of reverse transcriptase in therapy of HIV-infection].
    Galegov GA
    Antibiot Khimioter; 2005; 50(4):23-6. PubMed ID: 16392336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.